Sponsor pipeline

Annexon, Inc. clinical trial pipeline

Get alerts when Annexon, Inc.'s trials change

3 active trials 1 recruiting 3 Phase 3 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-08

What changed in the last 30 days

2026-10-07
Primary completion pushed: 2026-10-31 → 2027-07-31
Primary endpoint(s) modified
NCT06510816 A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of… · Phase 3

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-08 NCT07807969 An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 3
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07020819 An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in… Guillain-Barre Syndrome Recruiting 2026-05-28
NCT06510816 A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of… Geographic Atrophy Active, Not Recruiting 2026-10-06
NCT07807969 An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in… Geographic Atrophy Not Yet Recruiting 2026-09-08
Get alerts when Annexon, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free